This article was reviewed by Lynn Marie Morski, MD, JD. Ozempic Stomach Paralysis: Risks & Treatments Key takeaways: Stomach ...
Zacks Investment Research on MSN
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its blockbuster ...
Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.
Zacks Investment Research on MSN
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...
There's growing interest among women to take GLP-1 drugs like semaglutide for weight loss after giving birth and while ...
A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...
Across the U.S., restaurants are seeing diners eat and drink less thanks to GLP-1 medications like Ozempic and Wegovy. The drugs, which suppress appetite, have reshaped dining behavior and even menu ...
4don MSNOpinion
Ozempic for All
Ensuring GLP-1s are covered by Medicaid in all states would save lives—and not be as costly as some people fear.
4don MSN
Michigan to limit Medicaid coverage for weight loss drugs to people with diabetes, morbid obesity
Michigan’s new bipartisan state budget will limit Medicaid coverage of a group of weight loss drugs whose use has exploded in popularity in recent years.
E! Online on MSN
Why Ashley Tisdale Decided Not to Take Ozempic for Weight Loss
High School Musical alum Ashley Tisdale detailed her decision not to use Ozempic to assist with weight loss after giving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results